1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 IgG1 1.2.3 IgG4 1.2.4 Others 1.3 Market by Application 1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Autoimmune 1.3.3 Tumor 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2016-2027) 2.2 Antibody Therapeutics and Blood Antibody Therapeutics Growth Trends by Regions 2.2.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Antibody Therapeutics and Blood Antibody Therapeutics Industry Dynamic 2.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Trends 2.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers 2.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges 2.3.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue 3.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue 3.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio 3.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2020 3.5 Antibody Therapeutics and Blood Antibody Therapeutics Key Players Head office and Area Served 3.6 Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service 3.7 Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Type 4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2022-2027) 5 Antibody Therapeutics and Blood Antibody Therapeutics Breakdown Data by Application 5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2016-2027) 6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type 6.2.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2027) 6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application 6.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2027) 6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country 6.4.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2016-2027) 7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type 7.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2027) 7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application 7.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2027) 7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country 7.4.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type 8.2.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application 8.3.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region 8.4.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2016-2027) 9.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type 9.2.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application 9.3.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country 9.4.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type 10.2.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application 10.3.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country 10.4.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Abbvie 11.2.1 Abbvie Company Details 11.2.2 Abbvie Business Overview 11.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.2.5 Abbvie Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.3.5 Johnson & Johnson Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Novartis Business Overview 11.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.5.5 Novartis Recent Development 11.6 Merck 11.6.1 Merck Company Details 11.6.2 Merck Business Overview 11.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.6.5 Merck Recent Development 11.7 Alexion Pharmaceuticals 11.7.1 Alexion Pharmaceuticals Company Details 11.7.2 Alexion Pharmaceuticals Business Overview 11.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.7.5 Alexion Pharmaceuticals Recent Development 11.8 Takeda 11.8.1 Takeda Company Details 11.8.2 Takeda Business Overview 11.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.8.5 Takeda Recent Development 11.9 Amgen 11.9.1 Amgen Company Details 11.9.2 Amgen Business Overview 11.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.9.5 Amgen Recent Development 11.10 Biogen 11.10.1 Biogen Company Details 11.10.2 Biogen Business Overview 11.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.10.5 Biogen Recent Development 11.11 UCB 11.11.1 UCB Company Details 11.11.2 UCB Business Overview 11.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.11.5 UCB Recent Development 11.12 Eli Lilly and Company 11.12.1 Eli Lilly and Company Company Details 11.12.2 Eli Lilly and Company Business Overview 11.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.12.5 Eli Lilly and Company Recent Development 11.13 AstraZeneca 11.13.1 AstraZeneca Company Details 11.13.2 AstraZeneca Business Overview 11.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction 11.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) 11.13.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of IgG1 Table 3. Key Players of IgG4 Table 4. Key Players of Others Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Regions (2016-2021) Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Regions (2022-2027) Table 11. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends Table 12. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers Table 13. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges Table 14. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2020) Table 18. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Antibody Therapeutics and Blood Antibody Therapeutics Product Solution and Service Table 22. Date of Enter into Antibody Therapeutics and Blood Antibody Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Roche Company Details Table 63. Roche Business Overview Table 64. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product Table 65. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 66. Roche Recent Development Table 67. Abbvie Company Details Table 68. Abbvie Business Overview Table 69. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product Table 70. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 71. Abbvie Recent Development Table 72. Johnson & Johnson Company Details Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product Table 75. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 76. Johnson & Johnson Recent Development Table 77. Bristol-Myers Squibb Company Details Table 78. Bristol-Myers Squibb Business Overview Table 79. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product Table 80. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 81. Bristol-Myers Squibb Recent Development Table 82. Novartis Company Details Table 83. Novartis Business Overview Table 84. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product Table 85. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 86. Novartis Recent Development Table 87. Merck Company Details Table 88. Merck Business Overview Table 89. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product Table 90. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 91. Merck Recent Development Table 92. Alexion Pharmaceuticals Company Details Table 93. Alexion Pharmaceuticals Business Overview Table 94. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product Table 95. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 96. Alexion Pharmaceuticals Recent Development Table 97. Takeda Company Details Table 98. Takeda Business Overview Table 99. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 100. Takeda Recent Development Table 101. Amgen Company Details Table 102. Amgen Business Overview Table 103. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product Table 104. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 105. Amgen Recent Development Table 106. Biogen Company Details Table 107. Biogen Business Overview Table 108. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product Table 109. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 110. Biogen Recent Development Table 111. UCB Company Details Table 112. UCB Business Overview Table 113. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product Table 114. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 115. UCB Recent Development Table 116. Eli Lilly and Company Company Details Table 117. Eli Lilly and Company Business Overview Table 118. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product Table 119. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 120. Eli Lilly and Company Recent Development Table 121. AstraZeneca Company Details Table 122. AstraZeneca Business Overview Table 123. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product Table 124. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) & (US$ Million) Table 125. AstraZeneca Recent Development Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. IgG1 Features Figure 3. IgG4 Features Figure 4. Others Features Figure 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Autoimmune Case Studies Figure 7. Tumor Case Studies Figure 8. Others Case Studies Figure 9. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered Figure 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Regions: 2020 VS 2027 Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Regions (2022-2027) Figure 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2020 Figure 15. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2020 Figure 17. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2016-2021) Figure 18. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2022-2027) Figure 19. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2016-2027) Figure 21. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2016-2027) Figure 22. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2016-2027) Figure 23. United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2016-2027) Figure 27. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2016-2027) Figure 28. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2016-2027) Figure 29. Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2016-2027) Figure 37. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2016-2027) Figure 38. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Region (2016-2027) Figure 39. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2016-2027) Figure 47. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2016-2027) Figure 48. Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2016-2027) Figure 49. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2016-2027) Figure 53. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2016-2027) Figure 54. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Country (2016-2027) Figure 55. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 59. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 63. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 64. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 65. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 66. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 67. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 68. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 69. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 70. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Roche Abbvie Johnson & Johnson Bristol-Myers Squibb Novartis Merck Alexion Pharmaceuticals Takeda Amgen Biogen UCB Eli Lilly and Company AstraZeneca